Business Description
Syndax Pharmaceuticals is a New York-based company focused on bringing new cancer treatments to market. Its two approved medicines target aggressive forms of leukemia and a serious complication that can arise after bone marrow transplants. The company is also working to expand the use of these treatments into additional conditions, including a form of colorectal cancer and a scarring lung disease, while continuing to develop further therapies through its own research and external partnerships.
